• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

19.05 USD 0.24 1.28%

As of 19:59:59 ET on 04/16/2014.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +4.84% 3-Month: +1.06% 3-Year: +20.00% 52-Week Range: 14.96 - 20.65
1-Month: -4.09% 1-Year: +27.84% 5-Year: +24.35% Beta vs MXWO: 0.83

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 19.05
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2014-04-16) 19.05
Assets (M) (on 2014-03-31) 1,611.46
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-04-11) 0.09
Dividend Yield (ttm) 14.37

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.56
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.84

Top Fund Holdings for FPHAX

Filing Date: 02/28/2014
Name Position Value % of Total
AbbVie Inc 1,961,790 99,874,729 6.135%
AstraZeneca PLC 1,391,400 94,281,264 5.791%
Sanofi 1,796,622 93,136,884 5.721%
Actavis plc 418,520 92,417,586 5.677%
Novartis AG 1,107,998 92,163,274 5.661%
Johnson & Johnson 911,300 83,948,956 5.156%
Bristol-Myers Squibb Co 1,518,410 81,644,906 5.015%
Perrigo Co PLC 487,952 80,238,827 4.929%
Teva Pharmaceutical Industries 1,442,489 71,965,776 4.420%
Merck & Co Inc 1,260,836 71,855,044 4.414%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil